Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invivac 2006/2007 Influenza Vaccine Study
NCT00345462Phase 3Withdrawn
- Sponsor
- Solvay
- Start
- Jun 2006
- Modality
- Targeted Liposomes, Recombinant Protein Vaccines, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of virosomal influenza vaccine in influenza, sponsored by Solvay. Planned start Jun 2006; status: withdrawn.
02
Drugs
virosomal influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00345462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345462.